VSGNE 择期腹主动脉瘤修复术后死亡风险预测模型在 VQI 中的外部验证
本研究在血管质量倡议(VQI)2010–2015 年择期腹主动脉瘤(AAA)修复样本中,外部验证新英格兰血管研究组(VSGNE)术后死亡风险预测模型,并与 Medicare、Vascular Governance Northwest 模型及 Glasgow 动脉瘤评分比较。VSGNE 模型外部验证 C 统计量为 0.802,判别能力优于其他模型,且在各风险五分位中预测准确。
要点
- VSGNE 模型仅用术前变量和计划修复方式,外部验证 C=0.802。
- VQI 外部样本 16,989 例,总体死亡率 0.9%。
- 判别能力优于 Medicare(0.780)、Vascular Governance Northwest(0.774)和 Glasgow 动脉瘤评分(0.639)。
核心结论
- VSGNE 简单风险预测模型在大型外部独立样本中预测择期 AAA 修复术后死亡具有很高判别能力,可按死亡风险可靠分层且优于其他既有模型。
研究设计与样本
- 基于 VQI AAA 数据库(2010–2015)择期 AAA 修复患者进行外部验证,并排除 VSGNE 病例。
- VSGNE 模型开发样本 4,431 例,总体死亡率 1.4%。
- 外部验证样本 16,989 例 VQI 病例,总体死亡率 0.9%。
主要发现
- VSGNE 模型内部验证 C=0.822,Hosmer-Lemeshow P=.309。
- 外部验证 C=0.802。
- Vuong 检验显示 VSGNE 模型拟合显著优于 Medicare 模型(C=0.780)、Vascular Governance Northwest(0.774)和 Glasgow 动脉瘤评分(0.639)。
- 在 5 个风险五分位中,VSGNE 模型预测的死亡率与观察值高度一致。
关键数值与推荐
- VSGNE 模型仅纳入术前变量:年龄、性别、冠心病史、慢性阻塞性肺疾病、脑血管病、肌酐水平和动脉瘤大小,以及计划修复方式。
- 判别能力以 C 统计量评估,校准与拟合优度用 Hosmer-Lemeshow 法评估。
- 模型间拟合比较采用 Vuong 检验。
临床怎么用
- 可用该术前变量模型对择期 AAA 修复患者进行死亡风险分层,辅助围手术期决策与患者沟通。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study is to externally validate a recently reported Vascular Study Group of New England (VSGNE) risk predictive model of postoperative mortality after elective abdominal aortic aneurysm (AAA) repair and to compare its predictive ability across different patients' risk categories and against the established risk predictive models using the Vascular Quality Initiative (VQI) AAA sample. METHODS: The VQI AAA database (2010-2015) was queried for patients who underwent elective AAA repair. The VSGNE cases were excluded from the VQI sample. The external validation of a recently published VSGNE AAA risk predictive model, which includes only preoperative variables (age, gender, history of coronary artery disease, chronic obstructive pulmonary disease, cerebrovascular disease, creatinine levels, and aneurysm size) and planned type of repair, was performed using the VQI elective AAA repair sample. The predictive value of the model was assessed via the C-statistic. Hosmer-Lemeshow method was used to assess calibration and goodness of fit. This model was then compared with the Medicare, Vascular Governance Northwest model, and Glasgow Aneurysm Score for predicting mortality in VQI sample. The Vuong test was performed to compare the model fit between the models. Model discrimination was assessed in different risk group VQI quintiles. RESULTS: Data from 4431 cases from the VSGNE sample with the overall mortality rate of 1.4% was used to develop the model. The internally validated VSGNE model showed a very high discriminating ability in predicting mortality (C = 0.822) and good model fit (Hosmer-Lemeshow P = .309) among the VSGNE elective AAA repair sample. External validation on 16,989 VQI cases with an overall 0.9% mortality rate showed very robust predictive ability of mortality (C = 0.802). Vuong tests yielded a significant fit difference favoring the VSGNE over then Medicare model (C = 0.780), Vascular Governance Northwest (0.774), and Glasgow Aneurysm Score (0.639). Across the 5 risk quintiles, the VSGNE model predicted observed mortality significantly with great accuracy. CONCLUSIONS: This simple VSGNE AAA risk predictive model showed very high discriminative ability in predicting mortality after elective AAA repair among a large external independent sample of AAA cases performed by a diverse array of physicians nationwide. The risk score based on this simple VSGNE model can reliably stratify patients according to their risk of mortality after elective AAA repair better than other established models.
引用
- Eslami MH, Rybin DV, Doros G, et al. External validation of Vascular Study Group of New England risk predictive model of mortality after elective abdominal aorta aneurysm repair in the Vascular Quality Initiative and comparison against established models. J Vasc Surg. 2017. PMID: 28807384. doi:10.1016/j.jvs.2017.05.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。